47
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPD

ORCID Icon, , ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 765-771 | Received 08 Jan 2024, Accepted 21 Feb 2024, Published online: 18 Mar 2024

References

  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 report). Available from: https://goldcopd.org. Accessed March 13, 2024.
  • Yun JH, Lamb A, Chase R, et al. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141(6):2037–47.e10. doi:10.1016/j.jaci.2018.04.010
  • Singh D, Agusti A, Martinez FJ, et al. Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease science committee 2022 review. Am J Respir Crit Care Med. 2022;206(1):17–24. doi:10.1164/rccm.202201-0209PP
  • Galiana A, Aguirre E, Rodriguez JC, et al. Sputum microbiota in moderate versus severe patients with COPD. Eur Respir J. 2014;43(6):1787–1790. doi:10.1183/09031936.00191513
  • Garcia-Nuñez M, Millares L, Pomares X, et al. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J Clin Microbiol. 2014;52(12):4217–4223. doi:10.1128/JCM.01967-14
  • Muggeo A, Perotin JM, Brisebarre A, et al. Extended bacteria culture-based clustering identifies a phenotype associating increased cough and Enterobacterales in stable chronic obstructive pulmonary disease. Front Microbiol. 2021;12:781797. doi:10.3389/fmicb.2021.781797
  • Beech AS, Lea S, Kolsum U, et al. Bacteria and sputum inflammatory cell counts; a COPD cohort analysis. Respir Res. 2020;21(1):289. doi:10.1186/s12931-020-01552-4
  • Kolsum U, Donaldson GC, Singh R, et al. Blood and sputum eosinophils in COPD; relationship with bacterial load. Respir Res. 2017;18(1):88. doi:10.1186/s12931-017-0570-5
  • Millares L, Pascual S, Montón C, et al. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulm Med. 2019;19(1):112. doi:10.1186/s12890-019-0867-x
  • Dingle TC, Butler-Wu SM. Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med. 2013;33(3):589–609. doi:10.1016/j.cll.2013.03.001
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2022 report). Available from: https://goldcopd.org. Accessed March 13, 2024.
  • Perotin JM, Adam D, Vella-Boucaud J, et al. Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severity. Respir Res. 2014;15:151. doi:10.1186/s12931-014-0151-9
  • Washko GR, Criner GJ, Mohsenifar Z, et al. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD. 2008;5(3):177–186. doi:10.1080/15412550802093025
  • Zysman M, Deslee G, Caillaud D, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1819–1824. doi:10.2147/COPD.S129787
  • Contoli M, Baraldo S, Conti V, et al. Airway inflammatory profile is correlated with symptoms in stable COPD: a longitudinal proof-of-concept cohort study. Respirology. 2020;25(1):80–88. doi:10.1111/resp.13607
  • Singh D, Bassi M, Balzano D, et al. COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum. J Cell Mol Med. 2021;25(2):905–918. doi:10.1111/jcmm.16146
  • Tan WC, Bourbeau J, Nadeau G, et al. High eosinophil counts predict decline in FEV 1: results from the CanCOLD study. Eur Respir J. 2021;57(5):2000838. doi:10.1183/13993003.00838-2020
  • Tangedal S, Nielsen R, Aanerud M, et al. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. PLoS One. 2019;14(9):e0222449. doi:10.1371/journal.pone.0222449
  • Dicker AJ, Huang JTJ, Lonergan M, et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2021;147(1):158–167. doi:10.1016/j.jaci.2020.02.040
  • Schumann DM, Tamm M, Kostikas K, Stolz D. Stability of the blood eosinophilic phenotype in stable and exacerbated COPD. Chest. 2019;156(3):456–465. doi:10.1016/j.chest.2019.04.012
  • Yip W, Li X, Koelwyn GJ, et al. Inhaled corticosteroids selectively alter the microbiome and host transcriptome in the small airways of patients with chronic obstructive pulmonary disease. Biomedicines. 2022;10(5):1110. doi:10.3390/biomedicines10051110